Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotransplant(BTRN) -- Ignore unavailable to you. Want to Upgrade?

To: N/E PATSFAN who wrote (501)	2/10/2000 10:50:00 PM
From: scaram(o)uche	Read Replies (2) \| Respond to of 1475

NEPF: You know, we should revive the old thread. There was NOTHING like the old gang for trying to point at stocks that were going to kick up heels and boogie. Carol is still picking biotechs, and had a hunk of CYTO today. KDUS is a special situation. It's worth about $3-4/share, IMO. But it's also come a long way and may have trouble regaining momentum?? OTOH, there are several potential events that could send it higher in a few minutes. BTRN.... yeah, well, we all know that from 2 to 12 3/4 for a good third-tier (actually, Mike M.-tier) is not saying much. It was a relatively SAFE tour, because of the quality science and management, but..... this "call" did not outperform, by any means. Fairly valued? Somewhere between $4/share and $200. Hope that helps. <g> You got some GENXY? Good, when we were first pointing at it? Cheers! Rick